38 related articles for article (PubMed ID: 38488758)
21. DC-CIK as a widely applicable cancer immunotherapy.
Wang S; Wang X; Zhou X; Lyerly HK; Morse MA; Ren J
Expert Opin Biol Ther; 2020 Jun; 20(6):601-607. PubMed ID: 32033522
[No Abstract] [Full Text] [Related]
22. Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer.
Fayyaz F; Yazdanpanah N; Rezaei N
Cell Commun Signal; 2022 Mar; 20(1):41. PubMed ID: 35346234
[TBL] [Abstract][Full Text] [Related]
23. Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy.
Zhang Y; Schmidt-Wolf IGH
J Cell Physiol; 2020 Dec; 235(12):9291-9303. PubMed ID: 32484595
[TBL] [Abstract][Full Text] [Related]
24. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
25. Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.
Meng Y; Yu Z; Wu Y; Du T; Chen S; Meng F; Su N; Ma Y; Li X; Sun S; Zhang G
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28301281
[TBL] [Abstract][Full Text] [Related]
26. Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.
Garofano F; Gonzalez-Carmona MA; Skowasch D; Schmidt-Wolf R; Abramian A; Hauser S; Strassburg CP; Schmidt-Wolf IGH
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484350
[TBL] [Abstract][Full Text] [Related]
27. Cytokine-induced killer (CIK) cells: from basic research to clinical translation.
Guo Y; Han W
Chin J Cancer; 2015 Mar; 34(3):99-107. PubMed ID: 25962508
[TBL] [Abstract][Full Text] [Related]
28. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2012 Jun; 12(6):673-84. PubMed ID: 22500889
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.
Giraudo L; Gammaitoni L; Cangemi M; Rotolo R; Aglietta M; Sangiolo D
Immunotherapy; 2015; 7(9):999-1010. PubMed ID: 26310715
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis.
Wang X; Tang S; Cui X; Yang J; Geng C; Chen C; Zhou N; Li Y
Medicine (Baltimore); 2018 Sep; 97(36):e12230. PubMed ID: 30200148
[TBL] [Abstract][Full Text] [Related]
31. Promising immunotherapy: Highlighting cytokine-induced killer cells.
Shirjang S; Alizadeh N; Mansoori B; Mahmoodpoor A; Kafil HS; Hojjat-Farsangi M; Yousefi M
J Cell Biochem; 2019 Jun; 120(6):8863-8883. PubMed ID: 30556298
[TBL] [Abstract][Full Text] [Related]
32. Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.
Ryu JI; Han MH; Cheong JH; Kim JM; Kim CH
Immunotherapy; 2017 Mar; 9(5):411-421. PubMed ID: 28357913
[TBL] [Abstract][Full Text] [Related]
33. Adoptive cell therapies in thoracic malignancies.
Lasvergnas J; Naigeon M; Chouahnia K; Zelek L; Chaput N; Duchemann B
Cancer Immunol Immunother; 2022 Sep; 71(9):2077-2098. PubMed ID: 35129636
[TBL] [Abstract][Full Text] [Related]
34. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer.
Zhong S; Zhang Y; Lu X; Meftahpour V
J Interferon Cytokine Res; 2024 Mar; 44(3):99-110. PubMed ID: 38488758
[TBL] [Abstract][Full Text] [Related]
35. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
[TBL] [Abstract][Full Text] [Related]
36. [Research Progress on Dendritic Cells Combined with Cytokine Induced Killer Cells Immunotherapy for Hematological Malignancies --Review].
Shi J; Ma TT; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1235-1239. PubMed ID: 30111437
[TBL] [Abstract][Full Text] [Related]
37. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells.
Jäkel CE; Schmidt-Wolf IG
Expert Opin Biol Ther; 2014 Jul; 14(7):905-16. PubMed ID: 24673175
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
Wang S; Wang Z
Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
